摘要
癌症被认为是美国的主要死因之一。虽然已经制定了预防策略,早期发现和改进的治疗方案,但仍需要新的靶点和治疗方法。自从得出结论认为癌症是由细胞的遗传和表观遗传改变介导的,许多研究小组正在关注通过营养,表观遗传机制和非编码RNAs预防和治疗的其他手段,这些手段已被证明可以控制基因表达,不同的功能在细胞水平。随着人类癌症中高通量测序的出现,鉴定疾病的新型生物标志物和治疗靶标的潜力已经大大增加,并导致许多在各种癌症中失调的非编码RNA的鉴定。基因表达和调节对于维持正常组织和细胞的稳态是重要的。并不罕见,由于转录靶标的表达增加或减少,特定基因的上调或下调与癌症相关。本综述重点介绍了营养在癌症中的作用以及非编码RNA的失调,特别强调了长链非编码RNA和不同癌症类型的microRNA。
关键词: 癌症,表观遗传学,非编码RNA,营养,预防,靶点,治疗
Current Cancer Drug Targets
Title:Transforming Cancer Epigenetics Using Nutritive Approaches and Noncoding RNAs
Volume: 18 Issue: 1
关键词: 癌症,表观遗传学,非编码RNA,营养,预防,靶点,治疗
摘要: Cancer is considered one of the leading causes of death in the United States. Although preventive strategies, early detection, and improved treatment options have been developed, novel targets and therapeutics are still needed. Since concluding that cancer is mediated by genetic and epigenetic alterations of the cell, many research groups are now focusing on other means of prevention and therapy via nutrition, epigenetic mechanisms, and non-coding RNAs which have been shown to control gene expression and have many different functions at the cellular level. With the advent of high-throughput sequencing in human cancer, the potential to identify novel biomarkers and therapeutic targets of disease has increased tremendously and led to the identification of many non-coding RNAs that are dysregulated in various cancers. Gene expression and regulation is important in maintaining the homeostasis of normal tissues and cells. Not uncommonly, up- or down-regulation of particular genes are associated with cancer as a result of increased or decreased expression of transcriptional targets. This review focuses on the role of nutrition in cancer and the dysregulation of non-coding RNAs with particular emphasis on long non-coding RNAs and microRNAs in different cancer types.
Export Options
About this article
Cite this article as:
Transforming Cancer Epigenetics Using Nutritive Approaches and Noncoding RNAs, Current Cancer Drug Targets 2018; 18 (1) . https://dx.doi.org/10.2174/1568009617666170203165326
DOI https://dx.doi.org/10.2174/1568009617666170203165326 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Innovative Cancer Drug Targets: A New Horizon in Oncology
Cancer remains one of the most challenging diseases, with its complexity and adaptability necessitating continuous research efforts into more effective and targeted therapeutic approaches. Recent years have witnessed significant progress in understanding the molecular and genetic basis of cancer, leading to the identification of novel drug targets. These include, but ...read more
Role of Immune and Genotoxic Response Biomarkers in Tumor Microenvironment in Cancer Diagnosis and Treatment
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process of exploring and investigating the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
The Impact of Cancer Neuroscience on Novel Brain Cancer Treatment
Brain cancer remains one of the most challenging malignancies due to its complexity and resistance to conventional therapies. Recent advancements in cancer neuroscience have transformed our understanding of the brain's tumor microenvironment, offering promising insights into novel treatments. By studying the intricate interactions between cancer cells and the nervous system, ...read more
Unraveling the Tumor Microenvironment and Potential Therapeutic Targets: Insights from Single-Cell Sequencing and Spatial Transcriptomics
This special issue will focus on unraveling the complexities of the tumor microenvironment (TME) and identifying key biomarkers for potential therapeutic targets using advanced multi-omics techniques, such as single-cell sequencing and spatial transcriptomics. We seek original research and comprehensive reviews that investigate the heterogeneity and dynamics of the TME, emphasizing ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mucosal Healing in Crohn’s Disease: Relevance for Clinical Outcomes
Current Drug Targets The Pathogenic Role of Persistent Milk Signaling in mTORC1- and Milk- MicroRNA-Driven Type 2 Diabetes Mellitus
Current Diabetes Reviews Transient Expression of Chicken Antimicrobial Peptides by Mouse Mammary Carcinoma Cells C127
Protein & Peptide Letters Targeting Aurora Kinases in Cancer Treatment
Current Drug Targets The HOX Genes Network in Uro-Genital Cancers: Mechanisms and Potential Therapeutic Implications
Current Medicinal Chemistry Hypoxia as an Initiator of Neuroinflammation: Microglial Connections
Current Neuropharmacology Benzofuran-Based Estrogen Receptor α Modulators as Anti-Cancer Therapeutics: In Silico and Experimental Studies
Current Medicinal Chemistry Design, Synthesis and Mode of Action of Some New 2-(4'-aminophenyl) benzothiazole Derivatives as Potent Antimicrobial Agents
Letters in Drug Design & Discovery Diagnostic, Prognostic, and Therapeutic Value of miR-148b in Human Cancers
Current Molecular Medicine A Unique Intracellular, Extracellular and Transmembrane Circulation of Potassium Ions in the Auditory Inner Ear as an Anticarcinogenic Principle? Part 1
Inflammation & Allergy - Drug Targets (Discontinued) Gallic Acid and Gallic Acid Derivatives: Effects on Drug Metabolizing Enzymes
Current Drug Metabolism Editorial
Current Medical Imaging Lipoprotein Like Nanoparticles Used in Drug and Gene Delivery
Current Pharmaceutical Design Targeting Glycosylation Aberrations to Improve the Efficiency of Cancer Phototherapy
Current Cancer Drug Targets Bioavailability of Quercetin: Problems and Promises
Current Medicinal Chemistry The In Vitro Anti-Cancer Activities of 17βH-Neriifolin Isolated from Cerbera odollam and its Binding Activity on Na+, K+-ATPase
Current Pharmaceutical Biotechnology Nanobiotechnology-based Drug Delivery in Brain Targeting
Current Pharmaceutical Biotechnology MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs
Current Drug Targets Impact of Metformin on Male Reproduction
Current Pharmaceutical Design Peripheral Benzodiazepine Receptor (PBR) New Insight in Cell Proliferation and Cell Differentiation Review
Current Clinical Pharmacology